The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Synbiotic 2000 fails to prevent a recurrence of Crohn’s disease following surgery

    Complications of Crohn’s disease (CD) lead to surgery in 70% to 90% of patients, and most of them experience a relapse.

    Synbiotic 2000 consists of a mixture of probiotics and prebiotics. The rationale for its use in this study was to alter the bacteria in the colon and hopefully lower the CD relapse rate after surgery.

    In a group of 30 patients following surgery, some were treated with Synbiotic 2000 and others with placebo, There was no difference in relapse rate between the 2 groups as measured by endoscopy or clinical assessment.

    In an earlier entry, Synbiotic 2000 was associated with beneficial effects in critically ill trauma patients.

    An abstract of a review of pre-, pro- and synbiotics — including Synbiotic 2000 — in critically ill patients by Professor Stig Bengmark from the department of hepatology, London Medical School, is here.

    Lucky day. The entire article has been posted here.

    4/9/07 22:32 JR

    Leave a Comment

    You must be logged in to post a comment.